SCHEMBL19762005

SCHEMBL19762005

Cc1ccc(O)c(CN(Cc2ccccc2)C(C)C)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
KDM4E B2RXH2 5/20 0.56
HPGD P15428 4/20 0.56
HSD17B10 Q99714 2/20 0.50
USP2 O75604 1/20 0.50
GFER P55789 1/20 0.42
RAB9A P51151 3/20 0.42
ATM Q13315 1/20 0.40
NPC1 O15118 2/20 0.38
KMT2A Q03164 6/20 0.38
MEN1 O00255 4/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
MAPT P10636 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17935482 0.81 KDM4E (0.60) ALDH1A1KDM4EHPGDHSD17B10USP2
SCHEMBL18539765 0.79 KDM4E (0.53) ALDH1A1KDM4EHPGDHSD17B10USP2
SCHEMBL3635237 0.76 TSHR (0.54) ALDH1A1KDM4EKMT2AMEN1HDAC6
SCHEMBL6379173 0.73 KDM4E (0.97) ALDH1A1KDM4EHPGDHSD17B10USP2
SCHEMBL31612527 0.71 CYP2C19 (0.55) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL11403516 0.71 KDM4E (0.62) ALDH1A1KDM4EHPGDHSD17B10USP2
Emoxypine SCHEMBL195347 0.70 KDM4E (0.72) ALDH1A1KDM4EHPGDHSD17B10USP2
Emoxypine SCHEMBL29362452 0.70 KDM4E (0.72) ALDH1A1KDM4EHPGDHSD17B10USP2
SCHEMBL17935215 0.70 KDM4E (0.62) ALDH1A1KDM4EHPGDHSD17B10USP2
SCHEMBL18550512 0.69 KDM4E (0.54) ALDH1A1KDM4EHPGDHSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180002312-A1 TETRA- AND PENTASUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS USEFUL IN THE TREATMENT OF RESPIRATORY DISEASES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180002312-A1 TETRA- AND PENTASUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS USEFUL IN THE TREATMENT OF RESPIRATORY DISEASES H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, F12, HRH4 ALDH1A1 1331/4885KDM4E 4220/4885HPGD 2958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.